Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Feb 3, 2017 | $62.8B |
| FY2017, ended Feb 2, 2018 | $83.8B |
| FY2018, ended Feb 1, 2019 | $77.3B |
| FY2019, ended Jan 31, 2020 | $87.8B |
| FY2020, ended Jan 29, 2021 | $120B |
| FY2021, ended Jan 28, 2022 | $155B |
| FY2022, ended Feb 3, 2023 | $129B |
| FY2023, ended Feb 2, 2024 | $126B |
| FY2024, ended Jan 31, 2025 | $146B |
| FY2025, ended Jan 30, 2026 | $150B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2026) | $117B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Feb 3, 2017 | $65.0B |
| FY2017, ended Feb 2, 2018 | $68.6B |
| FY2018, ended Feb 1, 2019 | $71.3B |
| FY2019, ended Jan 31, 2020 | $72.1B |
| FY2020, ended Jan 29, 2021 | $89.6B |
| FY2021, ended Jan 28, 2022 | $96.3B |
| FY2022, ended Feb 3, 2023 | $97.1B |
| FY2023, ended Feb 2, 2024 | $86.4B |
| FY2024, ended Jan 31, 2025 | $83.7B |
| FY2025, ended Jan 30, 2026 | $86.3B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2026) | $90.4B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Feb 3, 2017 | $3.09B | $4.45B |
| FY2017, ended Feb 2, 2018 | $3.45B | $3.94B |
| FY2018, ended Feb 1, 2019 | $2.31B | $5.02B |
| FY2019, ended Jan 31, 2020 | $4.28B | $2.81B |
| FY2020, ended Jan 29, 2021 | $5.83B | $9.26B |
| FY2021, ended Jan 28, 2022 | $8.44B | $8.26B |
| FY2022, ended Feb 3, 2023 | $6.44B | $6.76B |
| FY2023, ended Feb 2, 2024 | $7.73B | $6.18B |
| FY2024, ended Jan 31, 2025 | $6.96B | $7.70B |
| FY2025, ended Jan 30, 2026 | $6.65B | $7.65B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2026) | $6.64B | $7.00B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Feb 3, 2017 | $558M |
| FY2017, ended Feb 2, 2018 | $588M |
| FY2018, ended Feb 1, 2019 | $511M |
| FY2019, ended Jan 31, 2020 | $716M |
| FY2020, ended Jan 29, 2021 | $4.69B |
| FY2021, ended Jan 28, 2022 | $1.13B |
| FY2022, ended Feb 3, 2023 | $1.35B |
| FY2023, ended Feb 2, 2024 | $921M |
| FY2024, ended Jan 31, 2025 | $1.76B |
| FY2025, ended Jan 30, 2026 | $982M |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2026) | $3.17B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Feb 3, 2017 | $15.7B |
| FY2017, ended Feb 2, 2018 | $17.0B |
| FY2018, ended Feb 1, 2019 | $16.2B |
| FY2019, ended Jan 31, 2020 | $19.3B |
| FY2020, ended Jan 29, 2021 | $21.8B |
| FY2021, ended Jan 28, 2022 | $24.3B |
| FY2022, ended Feb 3, 2023 | $33.8B |
| FY2023, ended Feb 2, 2024 | $35.8B |
| FY2024, ended Jan 31, 2025 | $35.3B |
| FY2025, ended Jan 30, 2026 | $39.8B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2026) | $37.6B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 34.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Feb 3, 2017 | 857M |
| FY2017, ended Feb 2, 2018 | 826M |
| FY2018, ended Feb 1, 2019 | 796M |
| FY2019, ended Jan 31, 2020 | 755M |
| FY2020, ended Jan 29, 2021 | 717M |
| FY2021, ended Jan 28, 2022 | 662M |
| FY2022, ended Feb 3, 2023 | 596M |
| FY2023, ended Feb 2, 2024 | 572M |
| FY2024, ended Jan 31, 2025 | 560M |
| FY2025, ended Jan 30, 2026 | 560M |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2026) | 561M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Feb 3, 2017 | $3.60B | $90.0M |
| FY2017, ended Feb 2, 2018 | $3.19B | $99.0M |
| FY2018, ended Feb 1, 2019 | $3.04B | $74.0M |
| FY2019, ended Jan 31, 2020 | $4.31B | $98.0M |
| FY2020, ended Jan 29, 2021 | $4.97B | $155M |
| FY2021, ended Jan 28, 2022 | $13.0B | $230M |
| FY2022, ended Feb 3, 2023 | $14.1B | $223M |
| FY2023, ended Feb 2, 2024 | $6.14B | $210M |
| FY2024, ended Jan 31, 2025 | $4.05B | $221M |
| FY2025, ended Jan 30, 2026 | $211M | $247M |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2026) | $464M | $262M |
Valuation
At current price- Market Cap
- $111B
- P/E
- 16.7×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.2×
- Price / Book
- n/m. Market cap / shareholders' equity
- EV / EBITDA
- 11.4×
Growth
Trailing 12 months- Revenue (TTM)
- $90.4B
- Revenue Growth YoY
- 8.2%
- Revenue CAGR 3Y
- −3.8%
- Revenue CAGR 5Y
- −0.8%
- EPS Growth YoY
- −3.0%
- Net Income Growth YoY
- −3.1%
Profitability
Trailing 12 months- Gross Margin
- 33.1%
- Operating Margin
- 11.4%
- Net Margin
- 7.3%
- FCF Margin
- 7.7%
- Return on Equity
- n/m. Net income (TTM) / average equity
Earnings
Trailing 12 months- Net Income
- $6.64B
- EPS (diluted)
- $11.83
- EBITDA
- $12.8B
- Operating Income
- $10.3B
Balance Sheet
As of Jul 31, 2026- Cash and cash equivalents
- $3.17B
- Total Debt
- $37.6B
- Net Debt
- $34.4B
- Total Assets
- $55.9B
- Total Liabilities
- $63.3B
- Shareholders' Equity
- −$7.44B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $9.26B
- Capital Expenditure
- $2.26B
- Free Cash Flow
- $7.00B
Dividends and risk
Last 12 months- Dividend Yield
- 2.5%
- Dividend / Share
- $4.90
- Beta (5Y)
- 0.88
Every ratio is calculated from the company’s reported figures.